Valuation: Beijing Hotgen Biotech Co., Ltd.

Market Cap 1.05TCr 155.04Cr 135.98Cr 125.95Cr 115.88Cr 219.19Cr 15TCr 223.45Cr 1.5TCr 588.74Cr 7.29TCr 582.18Cr 569.45Cr 25TCr P/E 2024
-29.9x
P/E 2025 -68.6x
Enterprise Value 919.56Cr 135.62Cr 118.95Cr 110.17Cr 101.37Cr 191.73Cr 13TCr 195.47Cr 1.31TCr 514.99Cr 6.37TCr 509.26Cr 498.12Cr 22TCr EV / Sales 2024
8.74x
EV / Sales 2025 32.3x
Free-Float
67.8%
Yield 2024 *
-
Yield 2025 -
1 day+4.66%
1 week-7.36%
Current month+44.41%
1 month+52.66%
3 months+4.25%
6 months-33.32%
Current year-22.80%
1 week 112.13
Extreme 112.13
140.97
1 month 73.44
Extreme 73.44
143.99
Current year 73.44
Extreme 73.44
214.78
1 year 73.44
Extreme 73.44
262.22
3 years 22.94
Extreme 22.94
262.22
5 years 22.94
Extreme 22.94
262.22
10 years 22.94
Extreme 22.94
262.22
Manager TitleAgeSince
Chief Executive Officer 50 01/04/2006
Director of Finance/CFO 46 26/04/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 50 01/02/2014
Director/Board Member 56 01/07/2022
Director/Board Member 42 01/07/2022
Date Insider Type Main position Quantity % Market Cap.
11/11Sell

Chief Executive Officer

10,220 0.0111%
20/25/20Sell

Chief Executive Officer

1,66,460 0.1808%
20/25/20Sell

Chief Executive Officer

75,000 0.0815%
Change 5-day change 1-year change 3-year change Capi.($)
+4.66%-7.36%-33.12%+201.79% 155.04Cr
+1.80%-1.36%+222.89%+319.36% 2.1TCr
-0.92%-0.50%-41.30%-25.27% 952.8Cr
-2.75%-1.10%+23.13%+18.79% 686.15Cr
+5.61%+16.05%+252.04%-24.44% 530.3Cr
-1.52%+6.30%-21.09%-30.87% 512.42Cr
-0.73%-3.23%-39.02% - 482.25Cr
+0.29%+4.00%-23.02%-25.71% 419.85Cr
+10.01%-3.79%+66.21%+75.55% 342.43Cr
+2.15%+2.38%-15.80%-42.94% 262.94Cr
Average +1.82%+1.54%+39.09%+51.81% 644.46Cr
Weighted average by Cap. +1.12%-0.63%+85.72%+111.68%

Financials

2024 2025
Net sales 51Cr 7.53Cr 6.61Cr 6.12Cr 5.63Cr 11Cr 721.18Cr 11Cr 73Cr 29Cr 354.15Cr 28Cr 28Cr 1.22TCr 40Cr 5.97Cr 5.24Cr 4.85Cr 4.46Cr 8.44Cr 571.52Cr 8.61Cr 58Cr 23Cr 280.66Cr 22Cr 22Cr 969.25Cr
Net income -19Cr -2.82Cr -2.47Cr -2.29Cr -2.11Cr -3.98Cr -269.62Cr -4.06Cr -27Cr -11Cr -132.4Cr -11Cr -10Cr -457.26Cr -22Cr -3.19Cr -2.79Cr -2.59Cr -2.38Cr -4.5Cr -304.97Cr -4.59Cr -31Cr -12Cr -149.76Cr -12Cr -12Cr -517.2Cr
Net Debt -107.26Cr -16Cr -14Cr -13Cr -12Cr -22Cr -1.51TCr -23Cr -153.16Cr -60Cr -743.49Cr -59Cr -58Cr -2.57TCr -131.67Cr -19Cr -17Cr -16Cr -15Cr -27Cr -1.86TCr -28Cr -188.02Cr -74Cr -912.72Cr -73Cr -71Cr -3.15TCr
Logo Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co Ltd is a China-based company principally engaged in in-vitro diagnostics, innovative biological drugs, and biotechnology raw materials and artificial intelligence (AI) innovative drug services. The in-vitro diagnostics business mainly engages in the development and application of in-vitro diagnostic reagents and instruments. The innovative biological drug business focuses on two core areas: antibody drugs and nucleic acid drugs. The biotechnology raw materials and AI innovative drug services business mainly includes the core technology platform of biotechnology raw materials and the biomolecular AI design platform. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
946
Date Price Change Volume
14/26/14 CN¥125.06 +4.66% 49,13,577
13/26/13 CN¥119.49 -3.87% 55,99,091
10/26/10 CN¥124.30 +3.72% 70,92,594
09/26/09 CN¥119.84 +2.60% 68,21,194
08/26/08 CN¥116.80 -10.15% 66,66,592

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688068 Stock